Sybly Industries appoints Nand Kishore Ray and Dheeraj Kumar as executive directors
- Sybly Industries appointed Nand Kishore Ray and Dheeraj Kumar as additional executive directors
- Appointments effective October 21, 2026, approved by board meeting
- Both directors hold positions at Johnson Pharmacare Limited
- Neither appointee is related to existing key managerial personnel

*this image is generated using AI for illustrative purposes only.
Sybly Industries Limited appointed Nand Kishore Ray and Dheeraj Kumar as additional executive and non-independent directors effective October 21, 2026. The appointments were approved by the board during a meeting held the same day.
Both appointees are currently directors at Johnson Pharmacare Limited. The company stated that neither individual is related to existing directors or key managerial personnel of Sybly Industries. Additionally, both confirmed they are not debarred from holding office by any regulatory authority.
Board meeting details
The board meeting commenced at 2:15 pm and concluded at 2:45 pm on October 21, 2026. The appointments were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Consent forms (DIR-2) were submitted by both appointees, certifying their eligibility under the Companies Act, 2013.
Director profiles
Nand Kishore Ray, born in 1956, has a background in business. He holds one other directorship at Johnson Pharmacare Limited, where he also serves as the chairperson of the Stakeholders Relationship Committee. His DIN is 11626638.
Dheeraj Kumar, born in 2005, is also engaged in business. He holds one other directorship at Johnson Pharmacare Limited. His DIN is 11666616. The company noted that Mr. Kumar’s father is Mr. Nand Kishor Ray, indicating a familial link between the two new appointees, though the disclosure field for relationship between directors inter se was marked 'Not applicable' in the initial filing summary, likely referring to relationships with existing board members rather than among the new appointees themselves.
| Director Name | DIN | Birth Year | Other Listed Company | Role in Other Company |
|---|---|---|---|---|
| Nand Kishore Ray | 11626638 | 1956 | Johnson Pharmacare Ltd | Chairperson, SRC Committee |
| Dheeraj Kumar | 11666616 | 2005 | Johnson Pharmacare Ltd | Director |
Compliance declarations
Both directors submitted self-declarations confirming they are not debarred from accessing the capital market or holding director positions by SEBI or any other authority. They also declared no convictions for offences related to company promotion, formation, or management in the last five years.
How will the addition of two directors from Johnson Pharmacare Limited influence Sybly Industries' strategic direction or potential synergies with the pharmaceutical sector?
What specific governance measures is Sybly Industries implementing to manage conflicts of interest given that both new appointees hold directorships at the same external company?
Given Dheeraj Kumar's young age (born 2005) and limited experience, how does the board plan to ensure effective oversight and compliance with fiduciary duties?
























